Vivani Medical Files 8-K
Ticker: VANI · Form: 8-K · Filed: Oct 3, 2025 · CIK: 1266806
Sentiment: neutral
Topics: 8-K, corporate-filing, financial-reporting
TL;DR
Vivani Medical filed an 8-K on Oct 3, 2025. Nothing major disclosed.
AI Summary
Vivani Medical, Inc. filed an 8-K on October 3, 2025, reporting on other events and financial statements. The company, formerly known as Second Sight Medical Products Inc., is incorporated in Delaware and headquartered in Alameda, California.
Why It Matters
This filing provides an update on Vivani Medical's corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain significant new information that would immediately impact the company's risk profile.
Key Numbers
- 001-36747 — SEC File Number (Identifies the company's filing with the SEC)
- 02-0692322 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Vivani Medical, Inc. (company) — Registrant
- October 3, 2025 (date) — Date of earliest event reported
- Second Sight Medical Products Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Alameda, California (location) — Address of principal executive offices
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates it pertains to 'Regulation FD Disclosure', 'Other Events', and 'Financial Statements and Exhibits'.
When was Vivani Medical, Inc. previously known by another name?
The company was formerly known as Second Sight Medical Products Inc., with a date of name change on October 10, 2003.
What is the principal business address of Vivani Medical, Inc.?
The principal executive offices are located at 1350 S. Loop Road, Alameda, California, 94502.
What is the SIC code for Vivani Medical, Inc.?
The Standard Industrial Classification code is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
What is the fiscal year end for Vivani Medical, Inc.?
The fiscal year end for Vivani Medical, Inc. is December 31 (1231).
Filing Stats: 585 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-10-03 08:41:16
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share VANI The Nasdaq Capital M
Filing Documents
- vani-20251003.htm (8-K) — 38KB
- ex991_1.htm (EX-99.1) — 13KB
- 0001753926-25-001582.txt ( ) — 239KB
- vani-20251003_def.xml (EX-101.DEF) — 1KB
- vani-20251003_pre.xml (EX-101.PRE) — 29KB
- vani-20251003_cal.xml (EX-101.CAL) — 1KB
- vani-20251003_lab.xml (EX-101.LAB) — 42KB
- vani-20251003.xsd (EX-101.SCH) — 4KB
- vani-20251003_htm.xml (XML) — 3KB
01
Item 7.01 Regulation FD Disclosure. On October 3, 2025, Vivani Medical, Inc. (the "Company") issued a press release titled " Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off ." A copy of the press release is attached as Exhibit 99.1 hereto. The information set forth under Item 7.01 and in Exhibit 99.1 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01
Item 8.01 Other Events. Withdrawal of Record Date for Cortigent Spin-off On October 3, 2025, the Company announced that it is temporarily withdrawing the previously-announced record date of October 8, 2025 for the proposed spinoff of its wholly-owned subsidiary, Cortigent, Inc., which is developing brain implant devices with cutting-edge neuromodulation technology, due to delays arising from the current shutdown of the U.S. federal government.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued by Vivani Medical, Inc. on October 3, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. VIVANI MEDICAL, INC. Date: October 3, 2025 By: /s/ Donald Dwyer Name: Donald Dwyer Title: Chief Business Officer